Clarivate Narrows Losses, Boosts Revenue Slightly in Q3

Ticker: CLVT · Form: 10-Q · Filed: 2025-10-29T00:00:00.000Z

Sentiment: mixed

Topics: Financial Performance, Debt Management, Share Repurchases, Operating Expenses, Net Loss Reduction, Information Services, AI Technology Risk

TL;DR

**CLVT is showing signs of a turnaround with narrower losses and debt reduction, but revenue growth remains a concern.**

AI Summary

Clarivate PLC reported a net loss of $28.3 million for the three months ended September 30, 2025, a significant improvement from the net loss of $65.6 million in the same period of 2024. For the nine months ended September 30, 2025, the net loss was $204.2 million, compared to a net loss of $444.9 million in the prior year. Revenues saw a slight increase to $623.1 million for the three months ended September 30, 2025, up from $622.2 million in 2024, but decreased to $1,838.2 million for the nine-month period from $1,893.7 million in 2024. Operating expenses decreased to $579.1 million for the quarter from $600.5 million, primarily due to the absence of goodwill and intangible asset impairments, which were $13.8 million in Q3 2024 and $316.6 million for the nine months ended September 30, 2024. The company repurchased and retired ordinary shares totaling $149.5 million during the nine months ended September 30, 2025, reducing outstanding shares from 691.4 million to 661.4 million. Long-term debt decreased to $4,419.0 million from $4,518.7 million at December 31, 2024, reflecting principal payments of $600.0 million offset by $500.0 million in new debt issuance. The company continues to face risks related to competition, data dependence, and the ability to leverage AI technologies.

Why It Matters

Clarivate's ability to significantly reduce its net loss, despite a slight revenue dip year-to-date, signals potential operational improvements and a more stable financial trajectory for investors. The aggressive share repurchase program, totaling $149.5 million, indicates management's confidence and a commitment to returning value to shareholders, which could support stock price stability. However, the competitive landscape in information services, coupled with the need to adapt to rapidly changing technology and leverage AI, remains a critical challenge. For customers, Clarivate's strategic focus on 'transformative intelligence' and supporting the 'innovation lifecycle' suggests continued investment in product development, which is crucial for maintaining its market position against rivals like RELX and Thomson Reuters.

Risk Assessment

Risk Level: medium — The company reported a net loss of $204.2 million for the nine months ended September 30, 2025, indicating ongoing profitability challenges. While long-term debt decreased by $99.7 million to $4,419.0 million, the debt level remains substantial, and the company issued $500.0 million in new debt during the period. The 'Cautionary Note Regarding Forward-Looking Statements' highlights significant risks including dependence on third parties for data, intense competition, and the ability to leverage AI technologies.

Analyst Insight

Investors should monitor Clarivate's upcoming earnings calls for further details on revenue growth strategies and the impact of its Value Creation Plan. The reduction in net loss and debt is positive, but sustained profitability and organic revenue growth are key. Consider the competitive pressures and the company's ability to innovate with AI before making long-term commitments.

Financial Highlights

debt To Equity
1.29
revenue
$1,838.2M
operating Margin
1.6%
total Assets
$11,227.6M
total Debt
$4,419.0M
net Income
($204.2M)
eps
($0.30)
gross Margin
65.2%
cash Position
$318.7M
revenue Growth
-3.0%

Revenue Breakdown

SegmentRevenueGrowth
Total Revenues$623.1M+0.1%
Total Revenues (9M)$1,838.2M-3.0%

Key Numbers

Key Players & Entities

FAQ

What were Clarivate's revenues for the third quarter of 2025?

Clarivate's revenues for the three months ended September 30, 2025, were $623.1 million, a slight increase from $622.2 million reported in the same period of 2024.

How did Clarivate's net income (loss) change in Q3 2025 compared to Q3 2024?

Clarivate reported a net loss of $28.3 million for the three months ended September 30, 2025, which is a significant improvement from the net loss of $65.6 million reported in the third quarter of 2024.

What was Clarivate's total long-term debt as of September 30, 2025?

As of September 30, 2025, Clarivate's long-term debt stood at $4,419.0 million, a decrease from $4,518.7 million at December 31, 2024.

Did Clarivate repurchase any shares during the nine months ended September 30, 2025?

Yes, Clarivate repurchased and retired ordinary shares totaling $149.5 million during the nine months ended September 30, 2025, which is an increase from $100.0 million in the prior year period.

What are the primary segments Clarivate operates in?

Clarivate operates in three primary reportable segments: Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H), based on the different products and services offered and markets served.

What is Clarivate's stance on artificial intelligence (AI) technologies?

Clarivate acknowledges its ability to leverage artificial intelligence technologies ('AI') in its products and services, including generative AI, large language models ('LLMs'), machine learning, and other AI tools, as a factor that may impact its forward-looking statements.

What was the impact of goodwill and intangible asset impairments on Clarivate's operating expenses?

For the nine months ended September 30, 2025, there were no goodwill and intangible asset impairments, contributing to lower operating expenses. This contrasts sharply with the $316.6 million in impairments recorded during the same period in 2024.

How many ordinary shares of Clarivate were outstanding as of September 30, 2025?

The number of ordinary shares of Clarivate Plc outstanding as of September 30, 2025, was 661,435,069.

What are some key risks Clarivate faces according to the filing?

Key risks include dependence on third parties for data, increased accessibility to free information, intense competition, the ability to maintain high annual renewal rates, and the ability to leverage AI technologies effectively.

How much cash did Clarivate have at the end of Q3 2025?

Clarivate reported cash and cash equivalents, including restricted cash, of $318.7 million as of September 30, 2025, an increase from $295.2 million at the beginning of the period.

Risk Factors

Industry Context

Clarivate operates in the data, analytics, and intellectual property solutions market, facing intense competition from established players and emerging technology firms. The industry is characterized by a shift towards digital platforms, subscription-based models, and the increasing importance of AI and machine learning for data analysis and insight generation. Companies must continuously innovate to maintain relevance and capture market share.

Regulatory Implications

While no specific new regulatory changes are detailed, Clarivate's operations are subject to data privacy regulations (e.g., GDPR, CCPA) and intellectual property laws globally. Compliance with these evolving regulations is crucial to avoid fines and maintain customer trust. The company's reliance on data also means it must navigate potential antitrust scrutiny in certain markets.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

Goodwill and intangible asset impairments
A non-cash charge taken when the carrying value of goodwill or intangible assets on the balance sheet is deemed to be impaired, meaning their fair value is less than their book value. (The absence of these impairments in Q3 2025 ($0M vs $13.8M in Q3 2024) significantly contributed to the improved net income. The prior year's $316.6M impairment for the nine-month period highlights a past valuation challenge.)
Accumulated deficit
The cumulative net losses of a company that have not been offset by net income since its inception. (Clarivate's accumulated deficit stood at $7,517.7 million as of September 30, 2025, indicating a history of net losses that the company is working to overcome.)
Ordinary Shares Outstanding
The total number of shares of common stock that have been issued by a company and are held by investors. (The reduction from 691.4 million to 661.4 million shares outstanding due to buybacks suggests a capital allocation strategy aimed at increasing shareholder value per share.)
Deferred revenues
Revenue that has been received by a company but not yet earned, typically from subscriptions or advance payments for services not yet rendered. (The current portion of deferred revenues was $872.8 million, representing a significant portion of current liabilities, indicating a substantial backlog of future service delivery.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, Clarivate has significantly reduced its net loss from $444.9 million to $204.2 million, largely due to the absence of substantial goodwill and intangible asset impairments ($316.6 million in 9M 2024). Revenue, however, saw a slight decrease from $1,893.7 million to $1,838.2 million. Operating expenses also decreased substantially, primarily driven by the lack of impairments. The company has actively managed its share count through buybacks, reducing outstanding shares by 30 million, and has managed its debt levels, decreasing long-term debt while undertaking significant principal payments and new issuances.

Filing Stats: 4,673 words · 19 min read · ~16 pages · Grade level 8.7 · Accepted 2025-10-29 06:06:54

Filing Documents

Financial Information

Part I. Financial Information 4

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) 4 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Operations 5 Condensed Consolidated Statements of Comprehensive Income (Loss) 6 Condensed Consolidated Statements of Changes in Equity 7 Condensed Consolidated Statements of Cash Flows 9 Notes to the Condensed Consolidated Financial Statements 10

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 21

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 28

Controls and Procedures

Item 4. Controls and Procedures 28

Other Information

Part II. Other Information 30

Legal Proceedings

Item 1. Legal Proceedings 30

Risk Factors

Item 1A. Risk Factors 30

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30

Other Information

Item 5. Other Information 30

Exhibits

Item 6. Exhibits 31 Signature 32 1 Table of Contents Cautionary Note Regarding Forward-Looking Statements This quarterly report includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements" within the meaning of the "safe harbor provisions" of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "intends," "plans," "may," "will," or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this quarterly report and include statements regarding our intentions, beliefs, or current expectations concerning, among other things, anticipated cost savings, results of operations, financial condition, liquidity, prospects, growth, strategies, and the markets in which we operate. Such forward-looking statements are based on available current market material and management's expectations, beliefs, and forecasts concerning future events impacting us. Factors that may impact such forward-looking statements include: our dependence on third parties, including public sources, for data, information, and other services, and our relationships with such third parties; increased accessibility to free or relatively inexpensive information sources; our ability to compete in the highly competitive industry in which we operate, and potential adverse effects of this competition; our ability to maintain high annual renewal rates; our ability to maintain revenues if our products and services do not achieve and maintain broad market acceptance, or if we are unable

Financial Information

PART I. Financial Information

Financial Statements

Item 1. Financial Statements. CLARIVATE PLC Condensed Consolidated Balance Sheets (Unaudited) (In millions) September 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents, including restricted cash $ 318.7 $ 295.2 Accounts receivable, net 810.7 798.3 Prepaid expenses 93.9 85.9 Other current assets 67.8 65.2 Total current assets 1,291.1 1,244.6 Property and equipment, net 52.6 53.5 Other intangible assets, net 8,149.0 8,441.2 Goodwill 1,566.7 1,566.6 Other non-current assets 69.0 82.2 Deferred income taxes 49.2 48.5 Operating lease right-of-use assets 50.0 53.6 Total assets $ 11,227.6 $ 11,490.2 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 139.7 $ 124.5 Accrued compensation 129.6 119.2 Accrued expenses and other current liabilities 328.8 310.1 Current portion of deferred revenues 872.8 859.1 Current portion of operating lease liability 18.7 20.6 Total current liabilities 1,489.6 1,433.5 Long-term debt 4,419.0 4,518.7 Other non-current liabilities 98.6 72.5 Deferred income taxes 274.5 273.3 Operating lease liabilities 42.1 53.2 Total liabilities 6,323.8 6,351.2 Commitments and contingencies (Note 13) Shareholders' equity: Ordinary Shares, no par value; unlimited shares authorized; 661.4 and 691.4 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 12,867.9 12,978.8 Accumulated other comprehensive loss ( 446.4 ) ( 526.3 ) Accumulated deficit ( 7,517.7 ) ( 7,313.5 ) Total shareholders' equity 4,903.8 5,139.0 Total liabilities and shareholders' equity $ 11,227.6 $ 11,490.2 The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements. 4 Table of Contents CLARIVATE PLC Condensed Consolidated Statements of Operations (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, (In millions, except per share data) 2025 2024 2025 2024 Revenues $ 623.1 $ 622.2 $ 1,838.2 $ 1,

View on Read The Filing